Can CGM improve outcomes in poorly controlled type 1 diabetes?
Patient's Query
Hello doctor,
I am writing on behalf of my younger brother, who has type 1 diabetes and just turned 29 last month. He was diagnosed at 14 and has been on Insulin injections his whole life, but his control has been really inconsistent.
His last HbA1c came back at 9.8, which scared our whole family. His endocrinologist mentioned a CGM device as an option, but he keeps dismissing it, saying it's too expensive and uncomfortable. He had two severe hypoglycemic episodes this year, one where he passed out at work.
Will a CGM device genuinely help a T1D loved one live much longer at 29 with such poor current control, or is it just a fancy gadget? Our family is really worried about long-term complications like kidney and eye damage, and he's already showing early signs of these issues.
Please guide.
Hello,
Welcome to icliniq.com.
I understand your concerns.
What you have described regarding your brother represents a high-risk situation in long-standing type 1 diabetes mellitus. An HbA1c (glycated hemoglobin) of 9.8 indicates persistent hyperglycemia, and the history of two severe hypoglycemic episodes, including one with a loss of consciousness, suggests marked glucose variability. This combination significantly increases the risk of both acute events and long-term complications, such as kidney and eye damage, which you have already begun to notice.
A continuous glucose monitoring (CGM) device is not just an add-on or luxury in this context; it is a vital clinical tool. It continuously tracks glucose levels and, more importantly, how trends and provides alerts before sugars go dangerously low or high. In patients like your brother, this early warning can often prevent severe hypoglycemia. I have managed patients with similar profiles who experienced repeated blackouts, and after starting CGM, those episodes almost completely disappeared because they could intervene early.
CGM also helps improve overall control. By seeing the real-time glucose response to food, insulin, and activity, patients can make much more precise insulin adjustments. Over time, this enhances time-in-range and lowers HbA1c levels. Better control directly correlates with a slower progression of complications affecting the kidneys, eyes, and nerves.
Regarding whether it helps someone “live longer,” the device itself does not extend life, but the improved glycemic stability it provides clearly reduces complications and enhances long-term outcomes. For someone with poor control and recurrent severe hypoglycemia, using it is strongly recommended rather than merely optional.
Initial comfort concerns are common, but most patients adapt within a few days since the sensors are small and minimally intrusive. While cost is a real factor, in cases like this where there are already severe lows and early complications, the benefits are significant. Even a short trial often helps patients accept it once they experience the difference.
I hope I have addressed all of your queries and concerns. Please follow up whenever needed.
Take care and have a nice day.
Same symptoms don't mean you have the same problem. Consult a doctor now!
Related Questions
Diabetes Patches: CGM and Insulin Patches for Diabetes Management
Continuous Glucose Monitoring During Gastrointestinal Surgery
What can a 25-year-old male do to overcome his tiredness and weight loss problems due to type 1 diabetes mellitus and hypothyroidism?
Is there any cure for type 1 diabetes mellitus other than insulin therapy?
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.